Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-005004

CVP,Strategy/Corp Development sold 12,500 shares at an average $92.33 ($1,154,142)

  • CVP,Strategy/Corp Development acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-08 Exercise or conversion : show line 1 in the form 10b5-1 +12,500 $36.75 $459,375 52,267.72 D
2024-04-08 Sale : show line 2 in the form 10b5-1 −100 $92.66 $9,266 52,167.72 D
2024-04-08 Sale : show line 3 in the form 10b5-1 −12,400 $92.33 $1,144,876 39,767.72 D
Open-market sales · 12,500 sh · avg $92.33 · $1,154,142

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-04-08 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −12,500 $36.75 2024-05-10 12,500 0 D
Loading xslF345X05/doc4.xml…